SS Innovations International (SSII) Cash from Financing Activities (2016 - 2026)

SS Innovations International (SSII) reported Cash from Financing Activities of $18.2 million for Q1 2026, down 18.95% on a YoY basis from $22.4 million in Q1 2025, and up 1222.47% sequentially from $1.4 million in Q4 2025.

SS Innovations International (SSII) Cash from Financing Activities (2016 - 2026) Analysis & Trends

SS Innovations International (SSII) has 11 years of Cash from Financing Activities data on file, last reported at $18.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities fell 18.95% year-over-year to $18.2 million; the trailing twelve-month figure through Mar 2026 stood at $21.9 million (down 24.91% YoY), and the FY2025 full-year result was $26.2 million, up 177.6% from the prior year.
  • Cash from Financing Activities climbed to $18.2 million in Q1 2026, from $1.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $22.4 million in Q1 2025 to a low of -$702098.0 in Q2 2025.
  • A 5-year average of $5.4 million and a median of $2.7 million in 2024 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities surged 15516.71% in 2022 and tumbled 126.45% in 2025, its largest moves.
  • Tracing SSII's Cash from Financing Activities over 5 years: stood at $3.1 million in 2022, then tumbled by 95.1% to $150563.0 in 2023, then soared by 2165.52% to $3.4 million in 2024, then tumbled by 59.74% to $1.4 million in 2025, then soared by 1222.47% to $18.2 million in 2026.
  • Business Quant data shows SSII's Cash from Financing Activities at $18.2 million in Q1 2026, $1.4 million in Q4 2025, and $3.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 SS Innovations International 699.75 Mn 676.14 Mn 5.33 Mn 18.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.16 Mn
Mar 31, 2026 18.16 Mn
Dec 31, 2025 1.37 Mn
Dec 31, 2025 1.37 Mn
Sep 30, 2025 3.09 Mn
Sep 30, 2025 3.09 Mn
Jun 30, 2025 -702,098.00
Jun 30, 2025 -702,098.00
Mar 31, 2025 22.41 Mn
Mar 31, 2025 22.41 Mn
Dec 31, 2024 3.41 Mn
Dec 31, 2024 3.41 Mn
Sep 30, 2024 722,336.00
Sep 30, 2024 722,336.00
Jun 30, 2024 2.65 Mn
Jun 30, 2024 2.65 Mn
Mar 31, 2024 2.64 Mn
Mar 31, 2024 2.64 Mn
Dec 31, 2023 150,563.00
Dec 31, 2023 150,563.00